BCL2 and cancer: Consequently, based on in vitro and in vivo findings in B16M cells (on the interaction between endothelial and metastatic cells, and the effect of ROS and RNS), GSH and Bcl-2 appear candidates to challenge survival of cancer cells with high metastatic potential.